Apertura Gene Therapy

Apertura is a biotechnology company that offers opportunities for treating currently incurable diseases. By simultaneously designing AAV capsids, regulatory elements, and payloads to overcome the limitations of current gene therapies, we are in a unique position to develop genetic medicines. Apertura is committed to advancing the field of gene therapy and believes that by collaborating with corporate and academic partners, patients, and disease foundations, we can maximize our impact.